{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:47:51Z","timestamp":1792003671047,"version":"4.4.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":116,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["12X6322N"],"award-info":[{"award-number":["12X6322N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-026-00967-z","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:36:17Z","timestamp":1775324177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bacteria of the lung microbiome and health biomarkers in chronic airway disease: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"12","author":[{"given":"Lucia","family":"Grassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Febe","family":"Heye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiaan","family":"Proesmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Abatih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axelle","family":"Van Daele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lies","family":"Lahousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Crabb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"967_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41392-023-01722-y","volume":"9","author":"R Li","year":"2024","unstructured":"Li, R., Li, J. & Zhou, X. Lung microbiome: new insights into the pathogenesis of respiratory diseases. Signal Transduct. Target Ther. 9, 19 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"967_CR2","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41590-019-0451-9","volume":"20","author":"TP Wypych","year":"2019","unstructured":"Wypych, T. P., Wickramasinghe, L. C. & Marsland, B. J. The influence of the microbiome on respiratory health. Nat. Immunol. 20, 1279\u20131290 (2019).","journal-title":"Nat. Immunol."},{"key":"967_CR3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12931-022-02132-4","volume":"23","author":"M Avalos-Fernandez","year":"2022","unstructured":"Avalos-Fernandez, M. et al. The respiratory microbiota alpha-diversity in chronic lung diseases: first systematic review and meta-analysis. Respir. Res. 23, 214 (2022).","journal-title":"Respir. Res."},{"key":"967_CR4","doi-asserted-by":"publisher","first-page":"210161","DOI":"10.1183\/20734735.0161-2021","volume":"18","author":"CD Campbell","year":"2022","unstructured":"Campbell, C. D., Barnett, C. & Sulaiman, I. A clinicians\u2019 review of the respiratory microbiome. Breathe 18, 210161 (2022).","journal-title":"Breathe"},{"key":"967_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jaci.2020.02.040","volume":"147","author":"AJ Dicker","year":"2021","unstructured":"Dicker, A. J. et al. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 147, 158\u2013167 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"967_CR6","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1128\/JCM.00432-15","volume":"53","author":"WG Flight","year":"2015","unstructured":"Flight, W. G. et al. Rapid Detection Of Emerging Pathogens And Loss Of Microbial Diversity Associated With Severe Lung Disease In Cystic Fibrosis. J. Clin. Microbiol 53, 2022\u20132029 (2015).","journal-title":"J. Clin. Microbiol"},{"key":"967_CR7","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jaci.2015.05.044","volume":"136","author":"YJ Huang","year":"2015","unstructured":"Huang, Y. J. et al. The airway microbiome in patients with severe asthma: Associations with disease features and severity. J. Allergy Clin. Immunol. 136, 874\u2013884 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"967_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1513\/AnnalsATS.201310-335OC","volume":"11","author":"GB Rogers","year":"2014","unstructured":"Rogers, G. B. et al. A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Ann. Am. Thorac. Soc. 11, 496\u2013503 (2014).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"967_CR9","doi-asserted-by":"publisher","unstructured":"Lee, S. H. et al. Characterization of microbiota in bronchiectasis patients with different disease severities. J. Clin. Med. 7. https:\/\/doi.org\/10.3390\/jcm7110429 (2018).","DOI":"10.3390\/jcm7110429"},{"key":"967_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jaci.2017.03.044","volume":"141","author":"SL Taylor","year":"2018","unstructured":"Taylor, S. L. et al. Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology. J. Allergy Clin. Immunol. 141, 94\u2013103.e115 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"967_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrmicro.2017.14","volume":"15","author":"WH Man","year":"2017","unstructured":"Man, W. H., de Steenhuijsen Piters, W. A. & Bogaert, D. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat. Rev. Microbiol 15, 259\u2013270 (2017).","journal-title":"Nat. Rev. Microbiol"},{"key":"967_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00210-023-02681-5","volume":"397","author":"M Chan","year":"2024","unstructured":"Chan, M. et al. Exploring the influence of the microbiome on the pharmacology of anti-asthmatic drugs. Naunyn Schmiedebergs Arch. Pharm. 397, 751\u2013762 (2024).","journal-title":"Naunyn Schmiedebergs Arch. Pharm."},{"key":"967_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.coi.2020.03.010","volume":"66","author":"SE Clark","year":"2020","unstructured":"Clark, S. E. Commensal bacteria in the upper respiratory tract regulate susceptibility to infection. Curr. Opin. Immunol. 66, 42\u201349 (2020).","journal-title":"Curr. Opin. Immunol."},{"key":"967_CR14","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/thoraxjnl-2018-211510","volume":"73","author":"N Acosta","year":"2018","unstructured":"Acosta, N. et al. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis. Thorax 73, 1016\u20131025 (2018).","journal-title":"Thorax"},{"key":"967_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jcf.2023.11.010","volume":"23","author":"GG Einarsson","year":"2024","unstructured":"Einarsson, G. G. et al. Longitudinal changes in the cystic fibrosis airway microbiota with time and treatment. J. Cyst. Fibros. 23, 252\u2013261 (2024).","journal-title":"J. Cyst. Fibros."},{"key":"967_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32901-0","volume":"13","author":"Q Xue","year":"2023","unstructured":"Xue, Q. et al. Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study. Sci. Rep. 13, 5715 (2023).","journal-title":"Sci. Rep."},{"key":"967_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1513\/AnnalsATS.201407-310OC","volume":"12","author":"ET Zemanick","year":"2015","unstructured":"Zemanick, E. T. et al. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods. Ann. Am. Thorac. Soc. 12, 221\u2013229 (2015).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"967_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1164\/rccm.202112-2704PP","volume":"206","author":"SH Chotirmall","year":"2022","unstructured":"Chotirmall, S. H. et al. Therapeutic Targeting of the Respiratory Microbiome. Am. J. Respir. Crit. Care Med 206, 535\u2013544 (2022).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"967_CR19","doi-asserted-by":"publisher","unstructured":"Taylor, S. L., Crabbe, A., Hoffman, L. R., Chalmers, J. D. & Rogers, G. B. Understanding the clinical implications of the \u201cnon-classical\u201d microbiome in chronic lung disease: a viewpoint. Eur. Respir. J. 63. https:\/\/doi.org\/10.1183\/13993003.02281-2023 (2024).","DOI":"10.1183\/13993003.02281-2023"},{"key":"967_CR20","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. Bmj 372, n160 (2021).","journal-title":"Bmj"},{"key":"967_CR21","doi-asserted-by":"publisher","first-page":"e8578","DOI":"10.1371\/journal.pone.0008578","volume":"5","author":"M Hilty","year":"2010","unstructured":"Hilty, M. et al. Disordered microbial communities in asthmatic airways. PLoS One 5, e8578 (2010).","journal-title":"PLoS One"},{"key":"967_CR22","unstructured":"Deeks, J.J., Higgins, J.P.T., Altman, D.G., McKenzie, J.E. & Veroniki, A.A. Chapter 10: Analysing data and undertaking meta\u2010analyses. Cochrane handbook for systematic reviews of interventions (2024)."},{"key":"967_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/0146621618795933","volume":"43","author":"JA Dahlke","year":"2019","unstructured":"Dahlke, J. A. & Wiernik, B. M. psychmeta: An R Package for Psychometric Meta-Analysis. Appl. Psychol. Meas. 43, 415\u2013416 (2019).","journal-title":"Appl. Psychol. Meas."},{"key":"967_CR24","unstructured":"Health, N. I. O. Quality assessment tool for observational cohort and cross-sectional studies. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"key":"967_CR25","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/s41380-022-01456-3","volume":"27","author":"AJ McGuinness","year":"2022","unstructured":"McGuinness, A. J. et al. A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Mol. Psychiatry 27, 1920\u20131935 (2022).","journal-title":"Mol. Psychiatry"},{"key":"967_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1171970","volume":"17","author":"AL McMath","year":"2023","unstructured":"McMath, A. L., Aguilar-Lopez, M., Cannavale, C. N., Khan, N. A. & Donovan, S. M. A systematic review on the impact of gastrointestinal microbiota composition and function on cognition in healthy infants and children. Front. Neurosci. 17, 1171970 (2023).","journal-title":"Front. Neurosci."},{"key":"967_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12931-024-02931-x","volume":"25","author":"YF Chen","year":"2024","unstructured":"Chen, Y. F. et al. The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study. Respir. Res 25, 308 (2024).","journal-title":"Respir. Res"},{"key":"967_CR28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12931-024-02983-z","volume":"25","author":"E Goeteyn","year":"2024","unstructured":"Goeteyn, E. et al. Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitro. Respir. Res. 25, 368 (2024).","journal-title":"Respir. Res."},{"key":"967_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2023.100194","volume":"3","author":"C Morimoto","year":"2024","unstructured":"Morimoto, C. et al. Sputum microbiota and inflammatory subtypes in asthma, COPD, and its overlap. J. Allergy Clin. Immunol. Glob. 3, 100194 (2024).","journal-title":"J. Allergy Clin. Immunol. Glob."},{"key":"967_CR30","doi-asserted-by":"publisher","first-page":"e0167649","DOI":"10.1371\/journal.pone.0167649","volume":"11","author":"TA Laguna","year":"2016","unstructured":"Laguna, T. A. et al. Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis. PLoS One 11, e0167649 (2016).","journal-title":"PLoS One"},{"key":"967_CR31","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3389\/fmicb.2020.01758","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. A Refined View of Airway Microbiome in Chronic Obstructive Pulmonary Disease at Species and Strain-Levels. Front. Microbiol 11, 1758 (2020).","journal-title":"Front. Microbiol"},{"key":"967_CR32","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1111\/all.16269","volume":"79","author":"MF Jabeen","year":"2024","unstructured":"Jabeen, M. F. et al. Species-level, metagenomic and proteomic analysis of microbe-immune interactions in severe asthma. Allergy 79, 2966\u20132980 (2024).","journal-title":"Allergy"},{"key":"967_CR33","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1111\/all.15776","volume":"78","author":"A Versi","year":"2023","unstructured":"Versi, A. et al. Haemophilus influenzae and Moraxella catarrhalis in sputum of severe asthma with inflammasome and neutrophil activation. Allergy 78, 2906\u20132920 (2023).","journal-title":"Allergy"},{"key":"967_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1323613","volume":"15","author":"Y Yue","year":"2024","unstructured":"Yue, Y. et al. Sputum microbe community alterations induced by long-term inhaled corticosteroid use are associated with airway function in chronic obstructive pulmonary disease patients based on metagenomic next-generation sequencing (mNGS). Front Pharm. 15, 1323613 (2024).","journal-title":"Front Pharm."},{"key":"967_CR35","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1016\/S2666-5247(21)00035-5","volume":"2","author":"MY Ramsheh","year":"2021","unstructured":"Ramsheh, M. Y. et al. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis. Lancet Microbe 2, e300\u2013e310 (2021).","journal-title":"Lancet Microbe"},{"key":"967_CR36","doi-asserted-by":"publisher","first-page":"e62917","DOI":"10.1371\/journal.pone.0062917","volume":"8","author":"ET Zemanick","year":"2013","unstructured":"Zemanick, E. T. et al. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PLoS One 8, e62917 (2013).","journal-title":"PLoS One"},{"key":"967_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03278-x","volume":"20","author":"L Su","year":"2022","unstructured":"Su, L. et al. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices. J. Transl. Med. 20, 76 (2022).","journal-title":"J. Transl. Med."},{"key":"967_CR38","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3389\/fmicb.2020.01647","volume":"11","author":"HY Liu","year":"2020","unstructured":"Liu, H. Y. et al. The interactions of airway bacterial and fungal communities in clinically stable asthma. Front. Microbiol. 11, 1647 (2020).","journal-title":"Front. Microbiol."},{"key":"967_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12866-023-02757-5","volume":"23","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Upper respiratory tract microbiota is associated with small airway function and asthma severity. BMC Microbiol. 23, 13 (2023).","journal-title":"BMC Microbiol."},{"key":"967_CR40","doi-asserted-by":"publisher","unstructured":"Chalmers, J. D. et al. Targeting neutrophil serine proteases in bronchiectasis. Eur. Respir. J. 65. https:\/\/doi.org\/10.1183\/13993003.01050-2024 (2025).","DOI":"10.1183\/13993003.01050-2024"},{"key":"967_CR41","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","volume":"9","author":"HR Keir","year":"2021","unstructured":"Keir, H. R. et al. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study. Lancet Respir. Med. 9, 873\u2013884 (2021).","journal-title":"Lancet Respir. Med."},{"key":"967_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jaci.2017.04.022","volume":"141","author":"AJ Dicker","year":"2018","unstructured":"Dicker, A. J. et al. Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 141, 117\u2013127 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"967_CR43","doi-asserted-by":"publisher","first-page":"e1112","DOI":"10.1093\/infdis\/jiae232","volume":"230","author":"S Budroni","year":"2024","unstructured":"Budroni, S. et al. Cytokine Biomarkers of Exacerbations in Sputum From Patients With Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study. J. Infect. Dis. 230, e1112\u2013e1120 (2024).","journal-title":"J. Infect. Dis."},{"key":"967_CR44","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","volume":"50","author":"BN Lambrecht","year":"2019","unstructured":"Lambrecht, B. N., Hammad, H. & Fahy, J. V. The Cytokines of Asthma. Immunity 50, 975\u2013991 (2019).","journal-title":"Immunity"},{"key":"967_CR45","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jcf.2021.10.009","volume":"21","author":"A Lepissier","year":"2022","unstructured":"Lepissier, A. et al. Inflammation biomarkers in sputum for clinical trials in cystic fibrosis: current understanding and gaps in knowledge. J. Cyst. Fibros. 21, 691\u2013706 (2022).","journal-title":"J. Cyst. Fibros."},{"key":"967_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-020-00345-8","volume":"10","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Fungal and bacterial microbiome dysbiosis and imbalance of trans-kingdom network in asthma. Clin. Transl. Allergy 10, 42 (2020).","journal-title":"Clin. Transl. Allergy"},{"key":"967_CR47","doi-asserted-by":"publisher","first-page":"412","DOI":"10.4168\/aair.2020.12.3.412","volume":"12","author":"JH Son","year":"2020","unstructured":"Son, J. H., Kim, J. H., Chang, H. S., Park, J. S. & Park, C. S. Relationship of microbial profile with airway immune response in eosinophilic or neutrophilic inflammation of asthmatics. Allergy Asthma Immunol. Res 12, 412\u2013429 (2020).","journal-title":"Allergy Asthma Immunol. Res"},{"key":"967_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12931-019-1085-z","volume":"20","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Airway host-microbiome interactions in chronic obstructive pulmonary disease. Respir. Res 20, 113 (2019).","journal-title":"Respir. Res"},{"key":"967_CR49","doi-asserted-by":"publisher","unstructured":"Zemanick, E. T. et al. Airway microbiota across age and disease spectrum in cystic fibrosis. Eur. Respir. J. 50. https:\/\/doi.org\/10.1183\/13993003.00832-2017 (2017).","DOI":"10.1183\/13993003.00832-2017"},{"key":"967_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12069","volume":"11","author":"YH Kim","year":"2021","unstructured":"Kim, Y. H. et al. Gram-negative microbiota is related to acute exacerbation in children with asthma. Clin. Transl. Allergy 11, e12069 (2021).","journal-title":"Clin. Transl. Allergy"},{"key":"967_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42862-y","volume":"9","author":"TE Woo","year":"2019","unstructured":"Woo, T. E. et al. A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome. Sci. Rep. 9, 6871 (2019).","journal-title":"Sci. Rep."},{"key":"967_CR52","doi-asserted-by":"publisher","first-page":"S246","DOI":"10.1093\/infdis\/jiaa655","volume":"223","author":"CY Zhao","year":"2021","unstructured":"Zhao, C. Y. et al. Microbiome data enhances predictive models of lung function in people with cystic fibrosis. J. Infect. Dis. 223, S246\u2013S256 (2021).","journal-title":"J. Infect. Dis."},{"key":"967_CR53","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.chom.2022.08.005","volume":"30","author":"L Li","year":"2022","unstructured":"Li, L. et al. Neisseria species as pathobionts in bronchiectasis. Cell Host Microbe 30, 1311\u20131327.e1318 (2022).","journal-title":"Cell Host Microbe"},{"key":"967_CR54","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1164\/rccm.202303-0489OC","volume":"210","author":"K Opron","year":"2024","unstructured":"Opron, K. et al. Loss of airway phylogenetic diversity is associated with clinical and pathobiological markers of disease development in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med 210, 186\u2013200 (2024).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"967_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1037037","volume":"13","author":"X Dang","year":"2022","unstructured":"Dang, X. et al. Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum microbiome signatures during clinical stability. Front. Microbiol. 13, 1037037 (2022).","journal-title":"Front. Microbiol."},{"key":"967_CR56","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.jaci.2015.10.017","volume":"137","author":"DR Denner","year":"2016","unstructured":"Denner, D. R. et al. Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways. J. Allergy Clin. Immunol. 137, 1398\u20131405.e1393 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"967_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0289-z","volume":"5","author":"V Narayanamurthy","year":"2017","unstructured":"Narayanamurthy, V. et al. The metabolic footprint of the airway bacterial community in cystic fibrosis. Microbiome 5, 67 (2017).","journal-title":"Microbiome"},{"key":"967_CR58","doi-asserted-by":"publisher","first-page":"e109798","DOI":"10.1371\/journal.pone.0109798","volume":"9","author":"J Renwick","year":"2014","unstructured":"Renwick, J. et al. The microbial community of the cystic fibrosis airway is disrupted in early life. PLoS One 9, e109798 (2014).","journal-title":"PLoS One"},{"key":"967_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00810-3","volume":"8","author":"L Cuthbertson","year":"2020","unstructured":"Cuthbertson, L. et al. Lung function and microbiota diversity in cystic fibrosis. Microbiome 8, 45 (2020).","journal-title":"Microbiome"},{"key":"967_CR60","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2147\/COPD.S167618","volume":"13","author":"W Diao","year":"2018","unstructured":"Diao, W. et al. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease. Int J. Chron. Obstruct. Pulmon Dis. 13, 2289\u20132299 (2018).","journal-title":"Int J. Chron. Obstruct. Pulmon Dis."},{"key":"967_CR61","doi-asserted-by":"publisher","unstructured":"Oriano, M. et al. Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis. Eur. Respir. J. 56. https:\/\/doi.org\/10.1183\/13993003.00769-2020 (2020).","DOI":"10.1183\/13993003.00769-2020"},{"key":"967_CR62","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S2213-2600(20)30557-9","volume":"9","author":"AJ Dicker","year":"2021","unstructured":"Dicker, A. J. et al. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study. Lancet Respir. Med. 9, 885\u2013896 (2021).","journal-title":"Lancet Respir. Med."},{"key":"967_CR63","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02198-23","volume":"11","author":"JJ Baty","year":"2023","unstructured":"Baty, J. J. et al. An oral commensal attenuates Pseudomonas aeruginosa-induced airway inflammation and modulates nitrite flux in respiratory epithelium. Microbiol. Spectr. 11, e0219823 (2023).","journal-title":"Microbiol. Spectr."},{"key":"967_CR64","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jcf.2021.04.012","volume":"20","author":"A Bertelsen","year":"2021","unstructured":"Bertelsen, A., Elborn, J. S. & Schock, B. C. Microbial interaction: Prevotella spp. reduce P. aeruginosa induced inflammation in cystic fibrosis bronchial epithelial cells. J. Cyst. Fibros. 20, 682\u2013691 (2021).","journal-title":"J. Cyst. Fibros."},{"key":"967_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1176044","volume":"14","author":"E Goeteyn","year":"2023","unstructured":"Goeteyn, E. et al. Commensal bacteria of the lung microbiota synergistically inhibit inflammation in a three-dimensional epithelial cell model. Front. Immunol. 14, 1176044 (2023).","journal-title":"Front. Immunol."},{"key":"967_CR66","doi-asserted-by":"publisher","unstructured":"Rigauts, C. et al. Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease. Eur. Respir. J. 59. https:\/\/doi.org\/10.1183\/13993003.01293-2021 (2022).","DOI":"10.1183\/13993003.01293-2021"},{"key":"967_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.824101","volume":"12","author":"A Tony-Odigie","year":"2022","unstructured":"Tony-Odigie, A., Wilke, L., Boutin, S., Dalpke, A. H. & Yi, B. Commensal Bacteria in the Cystic Fibrosis Airway Microbiome Reduce P. aeruginosa Induced Inflammation. Front. Cell Infect. Microbiol 12, 824101 (2022).","journal-title":"Front. Cell Infect. Microbiol"},{"key":"967_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2025.106076","volume":"234","author":"AR Maia","year":"2025","unstructured":"Maia, A. R. et al. Intranasal exposure to commensal bacterium Rothia mucilaginosa protects against influenza A virus infection. Antivir. Res. 234, 106076 (2025).","journal-title":"Antivir. Res."},{"key":"967_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1144157","volume":"13","author":"SN Stoner","year":"2023","unstructured":"Stoner, S. N., Baty, J. J., Novak, L. & Scoffield, J. A. Commensal colonization reduces Pseudomonas aeruginosa burden and subsequent airway damage. Front Cell Infect. Microbiol. 13, 1144157 (2023).","journal-title":"Front Cell Infect. Microbiol."},{"key":"967_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2024.100206","volume":"7","author":"L Grassi","year":"2024","unstructured":"Grassi, L. et al. Antibiofilm activity of Prevotella species from the cystic fibrosis lung microbiota against Pseudomonas aeruginosa. Biofilm 7, 100206 (2024).","journal-title":"Biofilm"},{"key":"967_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127680","volume":"283","author":"A Tony-Odigie","year":"2024","unstructured":"Tony-Odigie, A., Dalpke, A. H., Boutin, S. & Yi, B. Airway commensal bacteria in cystic fibrosis inhibit the growth of P. aeruginosa via a released metabolite. Microbiol. Res. 283, 127680 (2024).","journal-title":"Microbiol. Res."},{"key":"967_CR72","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1183\/20734735.000218","volume":"14","author":"C Vidaillac","year":"2018","unstructured":"Vidaillac, C., Yong, V. F. L., Jaggi, T. K., Soh, M. M. & Chotirmall, S. H. Gender differences in bronchiectasis: a real issue? Breathe 14, 108\u2013121 (2018).","journal-title":"Breathe"},{"key":"967_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.588584","volume":"8","author":"JE Hartmann","year":"2021","unstructured":"Hartmann, J. E., Albrich, W. C., Dmitrijeva, M. & Kahlert, C. R. The Effects of Corticosteroids on the Respiratory Microbiome: A Systematic Review. Front. Med. 8, 588584 (2021).","journal-title":"Front. Med."},{"key":"967_CR74","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12931-024-02836-9","volume":"25","author":"V Laiman","year":"2024","unstructured":"Laiman, V. et al. Cigarette smoke-induced dysbiosis: comparative analysis of lung and intestinal microbiomes in COPD mice and patients. Respir. Res. 25, 204 (2024).","journal-title":"Respir. Res."},{"key":"967_CR75","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1183\/09031936.00203013","volume":"44","author":"DJ Smith","year":"2014","unstructured":"Smith, D. J. et al. Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics. Eur. Respir. J. 44, 922\u2013930 (2014).","journal-title":"Eur. Respir. J."},{"key":"967_CR76","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mimet.2016.09.002","volume":"130","author":"A Hahn","year":"2016","unstructured":"Hahn, A. et al. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum. J. Microbiol. Methods 130, 95\u201399 (2016).","journal-title":"J. Microbiol. Methods"},{"key":"967_CR77","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1165\/rcmb.2019-0273TR","volume":"62","author":"SM Carney","year":"2020","unstructured":"Carney, S. M. et al. Methods in Lung Microbiome Research. Am. J. Respir. Cell Mol. Biol. 62, 283\u2013299 (2020).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"967_CR78","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1164\/rccm.200609-1354OC","volume":"175","author":"N Mayer-Hamblett","year":"2007","unstructured":"Mayer-Hamblett, N. et al. Association between pulmonary function and sputum biomarkers in cystic fibrosis. Am. J. Respir. Crit. Care Med. 175, 822\u2013828 (2007).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"967_CR79","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1164\/rccm.202009-3448OC","volume":"203","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Inflammatory endotype-associated airway microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: a multicohort longitudinal analysis. Am. J. Respir. Crit. Care Med. 203, 1488\u20131502 (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"967_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2024.107906","volume":"236","author":"Z Alfahl","year":"2025","unstructured":"Alfahl, Z. et al. Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasis. Respir. Med. 236, 107906 (2025).","journal-title":"Respir. Med."},{"key":"967_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2025.108042","volume":"240","author":"K Harwood","year":"2025","unstructured":"Harwood, K. et al. Relationship between sputum bacterial load and lung function in children with cystic fibrosis receiving tobramycin. Respir. Med. 240, 108042 (2025).","journal-title":"Respir. Med."},{"key":"967_CR82","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jcf.2020.03.008","volume":"19","author":"SL Taylor","year":"2020","unstructured":"Taylor, S. L. et al. Total bacterial load, inflammation, and structural lung disease in paediatric cystic fibrosis. J. Cyst. Fibros. 19, 923\u2013930 (2020).","journal-title":"J. Cyst. Fibros."},{"key":"967_CR83","doi-asserted-by":"publisher","unstructured":"Scott, J. E. & O\u2019Toole, G. A. The Yin and Yang of streptococcus lung infections in cystic fibrosis: a model for studying polymicrobial interactions. J. Bacteriol. 201. https:\/\/doi.org\/10.1128\/jb.00115-19 (2019).","DOI":"10.1128\/jb.00115-19"},{"key":"967_CR84","doi-asserted-by":"publisher","unstructured":"Ortiz Moyano, R. et al. The ability of respiratory commensal bacteria to beneficially modulate the lung innate immune response is a strain dependentcharacteristic. Microorganisms 8. https:\/\/doi.org\/10.3390\/microorganisms8050727 (2020).","DOI":"10.3390\/microorganisms8050727"},{"key":"967_CR85","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/s41591-021-01552-x","volume":"27","author":"C Mirzayi","year":"2021","unstructured":"Mirzayi, C. et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat. Med. 27, 1885\u20131892 (2021).","journal-title":"Nat. Med."},{"key":"967_CR86","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S2213-2600(18)30510-1","volume":"7","author":"KF Budden","year":"2019","unstructured":"Budden, K. F. et al. Functional effects of the microbiota in chronic respiratory disease. Lancet Respir. Med. 7, 907\u2013920 (2019).","journal-title":"Lancet Respir. Med."},{"key":"967_CR87","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/resp.13653","volume":"25","author":"K O\u2019Neill","year":"2020","unstructured":"O\u2019Neill, K. et al. Composition of airway bacterial community correlates with chest HRCT in adults with bronchiectasis. Respirology 25, 64\u201370 (2020).","journal-title":"Respirology"},{"key":"967_CR88","doi-asserted-by":"publisher","unstructured":"Ren, L. et al. Transcriptionally active lung microbiome and its association with bacterial biomass and host inflammatory status. mSystems 3. https:\/\/doi.org\/10.1128\/mSystems.00199-18 (2018).","DOI":"10.1128\/mSystems.00199-18"},{"key":"967_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02788-4","volume":"19","author":"CY Yang","year":"2021","unstructured":"Yang, C. Y. et al. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state. J. Transl. Med. 19, 121 (2021).","journal-title":"J. Transl. Med."}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00967-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00967-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00967-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:10:05Z","timestamp":1785521405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00967-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1038\/s41522-026-00967-z","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AC declares a pending patent application related to this work titled \u201cBacterial compositions with anti-inflammatory activity,\u201d published as US 2023\/0293599 A1 and EP 4188399 A2; both applications claim priority from PCT\/EP2021\/071330. The listed co-inventors are Aur\u00e9lie Crabb\u00e9, Tom Coenye, and Charlotte Rigauts, and the applicant is Ghent University. The application covers aspects of the manuscript relating to anti-inflammatory bacteria and their therapeutic potential.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"144"}}